Also trades as: ICCM.TA (TLV) · $vol 0M
ICCM NASDAQ
IceCure Medical Ltd
1W: -9.2%
1M: -30.5%
3M: -65.9%
YTD: -91.7%
1Y: -94.7%
3Y: -91.3%
5Y: -99.5%
$1.57
-0.12 (-7.10%)
Weekly Expected Move ±7.5%
$1
$1
$2
$2
$2
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$3.5M
52W Range1.55-42
Volume306,779
Avg Volume3,381,843
Beta0.45
Dividend—
Analyst Ratings
Company Info
CEOEyal Shamir
Employees68
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-08-26
Websiteicecure-medical.com
7 HaâEshel Street
Caesarea, HA 3079504
IL
Caesarea, HA 3079504
IL
972 4 623 0333
About IceCure Medical Ltd
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
Latest News
IceCure Secures China NMPA Approval for ProSense Cryoablation System
IceCure Medical wins China approval for ProSense cryoablation system
Quant Check: Top- and bottom-rated small-cap healthcare stocks post-earnings
IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue Estimates
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Peleg Meir | A-Award | 181,483 | — | 2026-08-14 |
| Good Shad | A-Award | 131,483 | — | 2026-08-14 |
| Tel-Tzure Tlalit Bus | A-Award | 101,483 | — | 2026-08-14 |
| Levav Shay | A-Award | 141,483 | — | 2026-08-14 |
| Dotan Merav Nir | A-Award | 73,890 | — | 2026-08-14 |